Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

A Dose of Optimism

Oracle Health: David Feinberg, MD

11 Nov 2025

Description

In this episode of A Dose of Optimism, host Omkar Kulkarni sits down with Dr. David Feinberg, Chairman of Oracle Health and one of the most influential leaders in modern medicine. From his beginnings as a pediatric psychiatrist to leading organizations like UCLA Health, Geisinger, Google Health, and now Oracle Health, Dr. Feinberg has always focused on one thing: making healthcare more compassionate, connected, and human.Together, they explore how artificial intelligence and data are transforming care, not by replacing doctors, but by empowering them. Dr. Feinberg shares how Oracle Health is building a more open, equitable system that connects patients, providers, and communities in ways that make care simpler and smarter. It’s a conversation about innovation, empathy, and the belief that better data can lead to better care, and ultimately, better lives.Episode Resources:Oracle Health EHROutlive: The Science and Art of Longevity by Peter AttiaConnect with David Feinberg:David Feinberg LinkedInOracle Health WebsiteOracle Health LinkedInConnect with us:KidsX WebsiteKidsX LinkedInChildren's Hospital L.A. WebsiteChildren's Hospital L.A. InstagramChildren's Hospital L.A. LinkedInLearn more about our sponsor:Nabla WebsiteNabla LinkedIn“The content, views, opinions, and information presented on this podcast do not reflect the views of Children’s Hospital Los Angeles or of the sponsors of the podcast. CHLA does not endorse the views, opinions and information presented on this podcast and CHLA specifically disclaims any legal liability or responsibility for the podcast’s content.” 

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.